These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16449949)

  • 1. Establishing melanocyte cultures in a serum-free system for transplantation in vitiligo patients.
    Czajkowski R; Placek W; Drewa T; Olszewska-Słonina D; Sir J; Kowaliszyn B; Weiss M
    Med Sci Monit; 2006 Feb; 12(2):CR63-9. PubMed ID: 16449949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous cultured melanocytes in vitiligo treatment.
    Czajkowski R; Placek W; Drewa T; Kowaliszyn B; Sir J; Weiss W
    Dermatol Surg; 2007 Sep; 33(9):1027-36; discussion 1035-6. PubMed ID: 17760593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of melanocytes transplantation methods for the treatment of vitiligo.
    Czajkowski R
    Dermatol Surg; 2004 Nov; 30(11):1400-5. PubMed ID: 15522021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
    Gupta S; Goel A; Kanwar AJ; Kumar B
    Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
    Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
    J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal grafting using the tops of suction blisters in the treatment of vitiligo.
    Koga M
    Arch Dermatol; 1988 Nov; 124(11):1656-8. PubMed ID: 3178247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culture of melanocytes obtained from normal and vitiligo subjects.
    Im S; Hann SK; Park YK; Kim HI
    Yonsei Med J; 1992 Dec; 33(4):344-50. PubMed ID: 1309014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction?
    Sahni K; Parsad D; Kanwar AJ; Mehta SD
    Dermatol Surg; 2011 Feb; 37(2):176-82. PubMed ID: 21269348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
    Issa CM; Rehder J; Taube MB
    Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cell survival of melanocyte spheroids in serum starvation condition.
    Lin SJ; Jee SH; Hsiao WC; Yu HS; Tsai TF; Chen JS; Hsu CJ; Young TH
    Biomaterials; 2006 Mar; 27(8):1462-9. PubMed ID: 16171860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous epidermal grafting with PUVA-irradiated donor skin for the treatment of vitiligo.
    Lee AY; Jang JH
    Int J Dermatol; 1998 Jul; 37(7):551-4. PubMed ID: 9679700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts.
    Kahn AM; Cohen MJ
    Dermatol Surg; 1998 Mar; 24(3):365-7. PubMed ID: 9537012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
    Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A
    Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of autologous melanocyte transfer in treatment of stable vitiligo.
    Pandya V; Parmar KS; Shah BJ; Bilimoria FE
    Indian J Dermatol Venereol Leprol; 2005; 71(6):393-7. PubMed ID: 16394479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.